Sign up
Pharma Capital

Optibiotix to launch SlimBiome in Nutri-Bites with US partner

Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) tells Proactive's Andrew Scott their SlimBiome weight management technology will be used in US partner Cereal Ingredients' (CII) Nutri-Bites range of cereal products.

The partnership will extend the application of SlimBiome® into products such as breakfast cereals and cookies, cakes as well as a range of healthy snacks, yoghurts, and cereal bars.

O'Hara also discusses the production and commercialisation agreement they signed earlier this week with Fine Foods & Pharmaceuticals


View full OPTI profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.